Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension

PHASE2CompletedINTERVENTIONAL
Enrollment

660

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

May 31, 2011

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

BI 10773

BI 10773 high dose once daily

DRUG

Metformin

open label comparator

DRUG

BI 10773

BI 10773 low dose once daily

DRUG

Sitagliptin

open label comparator

Trial Locations (137)

Unknown

1245.24.101001 Boehringer Ingelheim Investigational Site, Mission Viejo

1245.24.101028 Boehringer Ingelheim Investigational Site, Spring Valley

1245.24.101027 Boehringer Ingelheim Investigational Site, Walnut Creek

1245.24.101004 Boehringer Ingelheim Investigational Site, Clearwarter

1245.24.101005 Boehringer Ingelheim Investigational Site, Miami

1245.24.101024 Boehringer Ingelheim Investigational Site, Saint Cloud

1245.24.101014 Boehringer Ingelheim Investigational Site, Roswell

1245.24.101016 Boehringer Ingelheim Investigational Site, Staten Island

1245.24.101006 Boehringer Ingelheim Investigational Site, Wadsworth

1245.24.101023 Boehringer Ingelheim Investigational Site, Norristown

1245.24.101015 Boehringer Ingelheim Investigational Site, Dallas

1245.24.101025 Boehringer Ingelheim Investigational Site, Federal Way

1245.24.431002 Boehringer Ingelheim Investigational Site, Graz

1245.24.431001 Boehringer Ingelheim Investigational Site, Vienna

1245.24.431003 Boehringer Ingelheim Investigational Site, Vienna

1245.24.385104 Boehringer Ingelheim Investigational Site, Karlovac

1245.24.385103 Boehringer Ingelheim Investigational Site, Krapinske Toplice

1245.24.385106 Boehringer Ingelheim Investigational Site, Osijek

1245.24.385101 Boehringer Ingelheim Investigational Site, Zagreb

1245.24.420103 Boehringer Ingelheim Investigational Site, Brno

1245.24.420105 Boehringer Ingelheim Investigational Site, Brno

1245.24.420101 Boehringer Ingelheim Investigational Site, Břeclav

1245.24.420102 Boehringer Ingelheim Investigational Site, Hodonín

1245.24.372101 Boehringer Ingelheim Investigational Site, Tallinn

1245.24.372102 Boehringer Ingelheim Investigational Site, Tallinn

1245.24.372103 Boehringer Ingelheim Investigational Site, Tallinn

1245.24.372104 Boehringer Ingelheim Investigational Site, Tallinn

1245.24.372105 Boehringer Ingelheim Investigational Site, Tartu

1245.24.581006 Boehringer Ingelheim Investigational Site, Kerava

1245.24.581003 Boehringer Ingelheim Investigational Site, Oulu

1245.24.581004 Boehringer Ingelheim Investigational Site, Tampere

1245.24.581001 Boehringer Ingelheim Investigational Site, Turku

1245.24.3302A Boehringer Ingelheim Investigational Site, Bondy

1245.24.3302B Boehringer Ingelheim Investigational Site, Bondy

1245.24.3310A Boehringer Ingelheim Investigational Site, Caen

1245.24.3310C Boehringer Ingelheim Investigational Site, Caen

1245.24.3301A Boehringer Ingelheim Investigational Site, Corbeil-Essonnes

1245.24.3303A Boehringer Ingelheim Investigational Site, La Rochelle

1245.24.3303B Boehringer Ingelheim Investigational Site, La Rochelle

1245.24.3309A Boehringer Ingelheim Investigational Site, Nanterre

1245.24.3306A Boehringer Ingelheim Investigational Site, Narbonne

1245.24.3304A Boehringer Ingelheim Investigational Site, Reims

1245.24.3311B Boehringer Ingelheim Investigational Site, Saint-Mandé

1245.24.3305A Boehringer Ingelheim Investigational Site, Valenciennes

1245.24.3305B Boehringer Ingelheim Investigational Site, Valenciennes

1245.24.491011 Boehringer Ingelheim Investigational Site, Aschaffenburg

1245.24.491007 Boehringer Ingelheim Investigational Site, Frankfurt am Main

1245.24.491004 Boehringer Ingelheim Investigational Site, Hamburg

1245.24.491005 Boehringer Ingelheim Investigational Site, Hamburg

1245.24.491002 Boehringer Ingelheim Investigational Site, Melsungen

1245.24.491012 Boehringer Ingelheim Investigational Site, Nuremberg

1245.24.491008 Boehringer Ingelheim Investigational Site, Rehlingen-Siersburg

1245.24.491003 Boehringer Ingelheim Investigational Site, Saint Ingbert/Oberwürzbach

1245.24.491010 Boehringer Ingelheim Investigational Site, Sulzbach-Rosenberg

1245.24.361001 Boehringer Ingelheim Investigational Site, Budapest

1245.24.361003 Boehringer Ingelheim Investigational Site, Budapest

1245.24.361004 Boehringer Ingelheim Investigational Site, Budapest

1245.24.361005 Boehringer Ingelheim Investigational Site, Győr

1245.24.361002 Boehringer Ingelheim Investigational Site, Szombathely

1245.24.391006 Boehringer Ingelheim Investigational Site, Genova

1245.24.391003 Boehringer Ingelheim Investigational Site, Pisa

1245.24.391005 Boehringer Ingelheim Investigational Site, Treviso

1245.24.371101 Boehringer Ingelheim Investigational Site, Daugavpils

1245.24.371105 Boehringer Ingelheim Investigational Site, Kuldīga

1245.24.371106 Boehringer Ingelheim Investigational Site, Ogre

1245.24.371103 Boehringer Ingelheim Investigational Site, Riga

1245.24.371107 Boehringer Ingelheim Investigational Site, Riga

1245.24.371102 Boehringer Ingelheim Investigational Site, Talsi

1245.24.371104 Boehringer Ingelheim Investigational Site, Valmiera

1245.24.370102 Boehringer Ingelheim Investigational Site, Klaipėda

1245.24.370101 Boehringer Ingelheim Investigational Site, Vilnius

1245.24.471004 Boehringer Ingelheim Investigational Site, Ålesund

1245.24.471003 Boehringer Ingelheim Investigational Site, Hamar

1245.24.471005 Boehringer Ingelheim Investigational Site, Oslo

1245.24.471001 Boehringer Ingelheim Investigational Site, Stavanger

1245.24.401005 Boehringer Ingelheim Investigational Site, Alba Iulia

1245.24.401006 Boehringer Ingelheim Investigational Site, Baia Mare Maramures

1245.24.401002 Boehringer Ingelheim Investigational Site, Brasov

1245.24.401001 Boehringer Ingelheim Investigational Site, Bucharest

1245.24.401008 Boehringer Ingelheim Investigational Site, Bucharest

1245.24.401003 Boehringer Ingelheim Investigational Site, Galati

1245.24.401007 Boehringer Ingelheim Investigational Site, Satu Mare

1245.24.401004 Boehringer Ingelheim Investigational Site, Târgu Mureş

1245.24.701002 Boehringer Ingelheim Investigational Site, Kazan'

1245.24.701008 Boehringer Ingelheim Investigational Site, Moscow

1245.24.701009 Boehringer Ingelheim Investigational Site, Moscow

1245.24.701010 Boehringer Ingelheim Investigational Site, Moscow

1245.24.701004 Boehringer Ingelheim Investigational Site, Petrozavodsk

1245.24.701012 Boehringer Ingelheim Investigational Site, Saint Petersburg

1245.24.701013 Boehringer Ingelheim Investigational Site, Saint Petersburg

1245.24.701014 Boehringer Ingelheim Investigational Site, Saratov

1245.24.701005 Boehringer Ingelheim Investigational Site, Smolensk

1245.24.701006 Boehringer Ingelheim Investigational Site, Yaroslavl

1245.24.701007 Boehringer Ingelheim Investigational Site, Yaroslavl

1245.24.701001 Boehringer Ingelheim Investigational Site, Yekaterinburg

1245.24.421102 Boehringer Ingelheim Investigational Site, Bratislava

1245.24.421107 Boehringer Ingelheim Investigational Site, Bratislava

1245.24.421103 Boehringer Ingelheim Investigational Site, Lučenec

1245.24.421105 Boehringer Ingelheim Investigational Site, Nitra

1245.24.421106 Boehringer Ingelheim Investigational Site, Nitra

1245.24.421104 Boehringer Ingelheim Investigational Site, Nové Mesto nad Váhom

1245.24.421108 Boehringer Ingelheim Investigational Site, Prešov

1245.24.421101 Boehringer Ingelheim Investigational Site, Prievidza

1245.24.821006 Boehringer Ingelheim Investigational Site, Goyang

1245.24.821008 Boehringer Ingelheim Investigational Site, Goyang

1245.24.821007 Boehringer Ingelheim Investigational Site, Incheon

1245.24.821002 Boehringer Ingelheim Investigational Site, Pucheon

1245.24.821001 Boehringer Ingelheim Investigational Site, Seoul

1245.24.821004 Boehringer Ingelheim Investigational Site, Seoul

1245.24.821009 Boehringer Ingelheim Investigational Site, Suwon

1245.24.821003 Boehringer Ingelheim Investigational Site, Uijeongbu-si

1245.24.341002 Boehringer Ingelheim Investigational Site, Barcelona

1245.24.341001 Boehringer Ingelheim Investigational Site, Girona

1245.24.341010 Boehringer Ingelheim Investigational Site, L'Hospitalet de Llobregat (Barcelona)

1245.24.341004 Boehringer Ingelheim Investigational Site, Málaga

1245.24.341005 Boehringer Ingelheim Investigational Site, Palma Mallorca

1245.24.341006 Boehringer Ingelheim Investigational Site, Palma Mallorca

1245.24.341008 Boehringer Ingelheim Investigational Site, Santander

1245.24.461004 Boehringer Ingelheim Investigational Site, Härnösand

1245.24.461005 Boehringer Ingelheim Investigational Site, Lund

1245.24.461001 Boehringer Ingelheim Investigational Site, Stockholm

1245.24.886105 Boehringer Ingelheim Investigational Site, Changhua

1245.24.886107 Boehringer Ingelheim Investigational Site, Kaohsiung City

1245.24.886104 Boehringer Ingelheim Investigational Site, Taichun

1245.24.886106 Boehringer Ingelheim Investigational Site, Tainan City

1245.24.886101 Boehringer Ingelheim Investigational Site, Taipei

1245.24.886103 Boehringer Ingelheim Investigational Site, Taipei

1245.24.886102 Boehringer Ingelheim Investigational Site, Taoyuan District

1245.24.381007 Boehringer Ingelheim Investigational Site, Dnipro

1245.24.381003 Boehringer Ingelheim Investigational Site, Kharkiv

1245.24.381009 Boehringer Ingelheim Investigational Site, Kharkiv

1245.24.381010 Boehringer Ingelheim Investigational Site, Kharkiv

1245.24.381008 Boehringer Ingelheim Investigational Site, Kiev

1245.24.381002 Boehringer Ingelheim Investigational Site, Odesa

1245.24.381006 Boehringer Ingelheim Investigational Site, Vinnitsa

1245.24.381001 Boehringer Ingelheim Investigational Site, Vinnytsia

1245.24.381005 Boehringer Ingelheim Investigational Site, Vinnytsia

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00881530 - Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension | Biotech Hunter | Biotech Hunter